Tivic Health Systems, Inc. is a commercial health tech company advancing the field of bioelectronic medicine. The Company’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Its non-invasive and targeted approach to the treatment of inflammatory chronic health conditions is intended to give consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. The Company’s commercial product, ClearUP, is an FDA approved handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and available through online retailers and commercial distributors. ClearUP is sold in the United States directly to consumers on various platforms and through reseller channels. The Company is also focused on its intellectual property (IP) portfolio and research programs related to vagus nerve stimulation to expand its applications in non-invasive bioelectronic medicine.
BörsenkürzelTIVC
Name des UnternehmensTivic Health Systems Inc
IPO-datumNov 11, 2021
CEOMs. Jennifer Ernst
Anzahl der mitarbeiter7
WertpapierartOrdinary Share
GeschäftsjahresendeNov 11
Addresse47685 Lakeview Blvd
StadtFREMONT
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl94538
Telefon18882766888
Websitehttps://tivichealth.com/
BörsenkürzelTIVC
IPO-datumNov 11, 2021
CEOMs. Jennifer Ernst
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten